Sentences with phrase «in patients in the study»

He is now hoping to involve more bed - bound patients, including locked - in patients in the study.
«That was actually the predominant problem in patients in our study — 78 % of them had health insurance, but many of them were bankrupted anyway because there were gaps in their coverage like co-payments and deductibles and uncovered services,» says Dr. Woolhandler.

Not exact matches

While the new mid-stage study results from DNDi were impressive (they showed cure rates of 96 % to 97 % even for the sickest patients and those with liver scarring), more late - stage trials will be necessary before the drug is available on a large scale in the developing world.
A new study published in the New England Journal of Medicine finds that Valeant Pharmaceuticals» infamous price hikes for a pair of heart drugs called nitroprusside and isoproterenol — whose prices were increased by 310 % and 720 %, respectively — had significant downstream effects on patient care.
In all studies, we assigned patients measures of unconventional natural gas development activity.
We have now completed several health studies in partnership with the Geisinger Health System, which provides primary care to over 450,000 patients in Pennsylvania, including many residing in fracking areas.
Finally, in our study of symptoms, we found patients with higher unconventional natural gas development activity had higher odds of nasal and sinus, migraine headache and fatigue symptoms compared to those with lower activity.
A series of preliminary Mayo Clinic studies conducted in 2010 showed promise for the potential use of a chemical component of green tea (epigallocatechin gallate) in reducing the number of cancer cells in patients with chronic lymphocytic leukemia.
In the asthma study, we found increased odds among asthma patients of asthma hospitalizations, emergency department visits and a medication used for mild asthma attacks with higher unconventional natural gas development activity, compared to those with lower activity.
In our symptom study, we obtained questionnaires from 7,847 patients about nasal, sinus and other health symptoms.
In health care, this amounts to an hourly avalanche of new research papers, clinical trials, scientific studies, and patient health information.
The study participants were asked to develop strategies for landing the rocket mentally; this, in turn, allowed the patients to strategize ways of blocking out hallucinatory voices inside their heads.
The study, published today in the journal Trauma Surgery & Acute Care Open, found most of the fictional patients (71 %) were transferred from emergency directly to the operating theatre.
Patient experiences in the TV drama Grey's Anatomy are, unsurprisingly, portrayed inaccurately when compared with real - life trauma cases, according to a new study.
This study, published in the journal Philosophical Transactions of the Royal Society B, found that 22 patients who played the memory game made significantly fewer errors and needed significantly fewer attempts to remember the location of different patterns specific tests.
British - based GlaxoSmithKline, for example, conducts more than 100 studies a year in Canada, with the participation of some 10,500 patients in more than 1,000 medical centres.
BIIB098: MRI and relapse results from the phase 3 EVOLVE - MS - 1 study in patients with relapsing and remitting multiple sclerosis were presented at the 70th annual meeting of the American Academy of Neurology (AAN).
In a study cited in Shawn Achor's book The Happiness Advantage, three groups of patients treated their depression with medication, exercise, or a combination of the twIn a study cited in Shawn Achor's book The Happiness Advantage, three groups of patients treated their depression with medication, exercise, or a combination of the twin Shawn Achor's book The Happiness Advantage, three groups of patients treated their depression with medication, exercise, or a combination of the two.
ALKS 3831: Enrollment completed for ENLIGHTEN - 2, a six - month weight study compared to olanzapine in patients with stable schizophrenia.
FITBIT DATA AIDS RESEARCHERS IN UNDERSTANDING SURGERY RECOVERY: Fitbit data can help researchers and doctors predict the risk of 30 - and 60 - day readmission after surgery for cancer patients, according to a study published in the Annals of Behavioral MedicinIN UNDERSTANDING SURGERY RECOVERY: Fitbit data can help researchers and doctors predict the risk of 30 - and 60 - day readmission after surgery for cancer patients, according to a study published in the Annals of Behavioral Medicinin the Annals of Behavioral Medicine.
The company points to a simple resource allocation problem that's hindered the most effective patient care: the fact that it is physically impossible for oncologists to keep track of every study, every clinical trial, and every breakthrough in the wildly stratified world of cancer research.
A new study using lab - engineered microtumors allowed doctors to better predict if a cancer drug treatment will work in a patient.
Speaking of checkpoint inhibitor drugs... Merck's star cancer immunotherapy treatment Keytruda is facing some troubling clinical trial incidents which have now compelled the Food and Drug Administration (FDA) to halt three studies of the drug in multiple myeloma, a rare blood cancer, after a number of patient deaths.
To participate in the study, which concludes in July 2020, patients must be 18 years or older and have a histological - or cytological - proven diagnosis of a malignancy in the lung, breast, head and neck, genitourinary organs or ovaries or multiple myeloma.
The first step in the process is to surgically remove the patient's tumor and ensure that the patient is cancer free by confirming that there is no sign of cancer on blood tests and imaging studies.
But Amgen's rivals in the space, Sanofi and Regeneron (which have their own PCSK9 blocking medicine called Praluent), announced that an independent data monitoring committee hasn't seen enough significant evidence in a huge, 18,000 - patient cardiovascular outcomes trial to stop the study early.
Now, the firms are hoping that the completion of the study will show cardiovascular improvement in these patients, giving them a strong argument to present to reticent physicians.
Besides randomized controlled clinical trials, there are a number of ways researchers can study how a particular cancer treatment is playing out in the real world: there are retrospective studies, observational studies, and even prospective research done using patient registries.
The study, just published in Science, showed that the creation of what the researchers are calling microtumors can help predict drug effectiveness in cancer patients better than the current standard method of testing the drugs on rodents.
Other studies, meanwhile, are examining tryp's potential efficacy as an antifungal agent; and as a prognostic indicator in patients with brain cancer (as seen by increased uptake of the amino acid on a PET scan).
«While we are disappointed CheckMate - 026 did not meet its primary endpoint in this broad patient population, we remain committed to improving patient outcomes through our comprehensive development program, including the ongoing Phase III CheckMate - 227 study exploring the potential of the combination of Opdivo plus [our other cancer immunotherapy] Yervoy for PD - L1 positive patients, and Opdivo plus Yervoy, or Opdivo plus chemotherapy in PD - L1 negative patients,» he added.
The ENDEAVOUR Phase 3 study data monitoring committee recommended dosing be suspended after it found «an imbalance of mortality» in patients who used revusiran as compared to placebo.
«Patients in the study spent an average of approximately 27 minutes per day exercising over the course of an average 30 days in recovery,» wrote the researchers.
Amgen Executive Vice President of Research and Development Sean Harper said the study was designed to explore Kyprolis dosing regimens, noting that the the trial did not meet its goal in improving progression - free survival versus Velcade in patients who had not yet been treated for the disease.
«ICU care is inefficient, devoting substantial resources to patients less likely to benefit,» their study, published in the February edition of JAMA Internal Medicine, concluded.
Khosla referenced a study that asked a group of doctors to review patient data in order to determine whether the individual was in need of cardiac surgery.
HEART APP IMPROVES JOHNS HOPKINS» PATIENT OUTCOMES: A new cardiology - focused iPhone app is reducing readmission rates for heart attack patients, resulting in massive savings, according to a Johns Hopkins University study.
«Among both groups, patients taking Entresto had a 20 % or greater reduction in cardiovascular death or heart failure hospitalization compared to those taking enalapril,» Novartis said in a statement, citing conclusions based on analysis of data from the PARADIGM - HF study.
The study is patient - funded; participants, who range in age from late 30s through 80s, must pay $ 8,000 to take part, and live in or travel to Monterey for treatments and follow - up assessments.
Fernando Pagan, a GUMC associate professor of neurology who directs the Movement Disorders Program at MedStar Georgetown University Hospital, said that to his knowledge, the study «represents the first time a therapy appears to reverse — to a greater or lesser degree depending on stage of disease — cognitive and motor decline in patients with these neurodegenerative disorders.»
The technology has proved to be quite effective in studies — Embrace's algorithm detected 100 % of the seizures in a multi-site clinical study of 135 patients diagnosed with epilepsy.
When he co-founded Twine in 2013, Moore was a researcher at MIT studying how technology could be used to help patients improve their health.
Amarin's clinical development program for Vascepa includes a trial known as the REDUCE - IT cardiovascular outcomes study, an 8,175 - patient study commenced in 2011.
In parallel, adjudication will be completed for all MACE which occurred during the study, including adjudication for certain events which, per protocol, can not be finally adjudicated until patients complete their final site visit and results are available from certain non-invasive diagnostic testing conducted during such site visits.
REDUCE - IT is the first multinational cardiovascular outcomes study evaluating the effect of prescription pure EPA therapy, or any triglyceride - lowering therapy, as an add - on to statins in patients with high cardiovascular risk who, despite stable statin therapy, have elevated triglyceride levels (150 - 499 mg / dL).
Final patient visits will be followed by completing data entry for the more than 35,000 patient years of study in REDUCE - IT, and typical database quality control measures, known as cleaning.
In March 2018, patients in the study began to complete their final clinical site visits, a key step towards study completioIn March 2018, patients in the study began to complete their final clinical site visits, a key step towards study completioin the study began to complete their final clinical site visits, a key step towards study completion.
A large portion of the male and female patients enrolled in this outcomes study are anticipated to also be diagnosed with type 2 diabetes.
The National Institutes for Health also brought on six health - care groups in smaller cities to expand the study's reach and ensure a diverse roster of patients.
About half of the patients in a Kymriah study got cytokine - release syndrome, a response to the reprogrammed cells running loose in the body.
a b c d e f g h i j k l m n o p q r s t u v w x y z